Lv11
20 积分 2022-11-29 加入
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
2小时前
已完结
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China
3小时前
已完结
Genetically modified CD19-targeting IL-15 secreting NK cells for the treatment of systemic lupus erythematosus
1个月前
已完结
TIM3 Blockade in Dendritic Cells May Potentiate Antitumor Immunity
1个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
4个月前
已完结
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
5个月前
已完结
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy
5个月前
已完结
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
5个月前
已完结
Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression
5个月前
已完结
Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells
6个月前
已完结
皖公网安备34019202002308
